BOSTON, Feb. 27,
2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE:
DNA), which is building the leading platform for cell programming
and biosecurity, today announced that Co-Founder and CEO,
Jason Kelly, is scheduled to
participate in Cowen's 44th Annual Health Care Conference on
Tuesday, March 5, 2024 at
2:10 p.m. ET.
The presentation details and webcast link will be available on
Ginkgo's investor relations website at
https://investors.ginkgobioworks.com, and a replay will be made
available.
To ask a question ahead of the presentation, please submit them
to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to
investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell
programming, providing flexible, end-to-end services that solve
challenges for organizations across diverse markets, from food and
agriculture to pharmaceuticals to industrial and specialty
chemicals. Ginkgo's biosecurity and public health unit, Concentric
by Ginkgo, is building global infrastructure for biosecurity to
empower governments, communities, and public health leaders to
prevent, detect and respond to a wide variety of biological
threats. For more information, visit ginkgobioworks.com and
concentricbyginkgo.com, read our blog, or follow us on social media
channels such as X (@Ginkgo and @ConcentricByGBW), Instagram
(@GinkgoBioworks and @ConcentricByGinkgo), Threads
(@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-the-44th-annual-td-cowen-health-care-conference-302071898.html
SOURCE Ginkgo Bioworks